On its own, the IDEA-RS could discriminate who would later develop depression with moderate accuracy. That was helpful, but was it better when we added neurobiological markers? The short answer is yes.
When we started adding biological information, step by step, prediction kept improving.
The most important result came when we combined everything together: the sociodemographic risk score (IDEA-RS) plus all eight biological measures (the four cytokines, the KA/QA ratio, and the three amygdala reactivity measures). That combined model was able to discriminate adolescents who would develop depression with substantial accuracy – we shifted from moderate to excellent prediction. In other words, biology meaningfully sharpened the picture.
A biological risk score: making it practical
Statistics are useful, but if the long-term goal is a tool that can inform prevention, we also need something that is simple to apply and easy to replicate. So, we developed a biological risk score, called IDEA-BIO-RS.
We combined all the biological markers into one overall biological risk score, allowing us to group adolescents as biologically lower or higher risk for developing depression.
Even with biology alone, the difference was striking: in the biological high-risk group, 36% developed depression over three years, while in the biological low-risk group only 3% did.
But the most clinically meaningful results emerged when we combined biological and sociodemographic risk.
When two kinds of risk agree, risk becomes clearer
We grouped adolescents into four categories: low risk on both scores, high risk on both, or high risk on one but not the other.
Among adolescents who were low risk on both the sociodemographic score and the biological score, none developed depression during follow-up. At the other extreme, among adolescents who were high risk on both, 44% developed depression within three years. Those who were high on one score but not the other fell in between.
This pattern matters because it suggests two things at once. First, the combination can help identify a group where risk is high enough that targeted prevention could be justified. Second, it may also help identify a group where risk is very low, which is equally important if we want screening tools to be more precise and avoid unnecessary anxiety.
What this does and doesn’t mean
What this study shows is that integrating biology with sociodemographic context improves prediction in a meaningful way, and that a relatively simple biological risk score can complement an existing sociodemographic model.
It’s important to say what this study is not. It’s not evidence for a single biomarker of depression. Depression is too heterogeneous for that. Different people may reach similar symptoms through different pathways. That is precisely why composite scores are so appealing – they take into account the complexity of real life and its multidimensional nature.
Why I find this hopeful
In mental health, prevention often feels like something we talk about more than something we do. Studies like this are one way to make it more concrete. If we can identify adolescents who are likely to develop depression within a few years, not perfectly, but better than chance and better than sociodemographic risk alone, then we can begin building prevention pathways that are timely, targeted, and fair.
And I think that is why it was worthwhile to wait a couple of years. My hope is that, with a little patience, we can see this making real difference in people’s lives.
